mBio.01040-13.pdf
2 MB
Strep A connection to flu vaccine mist - Pubmed article
Thanks to @Sandi, from the M Seeker of Truth Chat page and frequent poster to our chat page too, for putting me on to this.
Thanks to @Sandi, from the M Seeker of Truth Chat page and frequent poster to our chat page too, for putting me on to this.
👍1🔥1
salmonella-mbandaka-chicken-outbreak-assessment_1.pdf
564.4 KB
European Centre for Disease Control: Xmas bundle (Drop 1 of 5)
It appears to be another one of those rare occasions where, the ECDC, remembers I'm on their press release list and send me a bundle of their reports. In this bundle we have everything from Covid19, to Ebola covered, so let's take a look shall we?
1) Multi-country outbreak of Salmonella Mbandaka ST413, possibly linked to consumption of chicken meat in the EU/EEA, Israel and the UK
2) Ebola disease outbreak caused by Sudan ebolavirus in Uganda, 2022
3) Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016-2020
4) Annex 1 (for paper 3): Estimated number of infections, number of attributable deaths and number of disabilityadjusted life 20162020years per 100 000 population, EU/EEA,
5) Annex 2 (for paper 3): Individual country results
It appears to be another one of those rare occasions where, the ECDC, remembers I'm on their press release list and send me a bundle of their reports. In this bundle we have everything from Covid19, to Ebola covered, so let's take a look shall we?
1) Multi-country outbreak of Salmonella Mbandaka ST413, possibly linked to consumption of chicken meat in the EU/EEA, Israel and the UK
2) Ebola disease outbreak caused by Sudan ebolavirus in Uganda, 2022
3) Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016-2020
4) Annex 1 (for paper 3): Estimated number of infections, number of attributable deaths and number of disabilityadjusted life 20162020years per 100 000 population, EU/EEA,
5) Annex 2 (for paper 3): Individual country results
Nov2022-ECDC-WHO-Executive-Summary_Final.pdf
148.6 KB
European Centre for Disease Control: Xmas bundle (Drop 2 of 5)
1) Surveillance of antimicrobial resistance in Europe, 2021 data (WHO Executive Summary)
2) HIV/AIDS surveillance in Europe 2022 (WHO collaborative study)
3) HIV Continuum of care Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress report
4) Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
5) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
1) Surveillance of antimicrobial resistance in Europe, 2021 data (WHO Executive Summary)
2) HIV/AIDS surveillance in Europe 2022 (WHO collaborative study)
3) HIV Continuum of care Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress report
4) Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
5) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
Supplement-1-List-of-publications.pdf
561.7 KB
European Centre for Disease Control: Xmas bundle (Drop 3 of 5)
1) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs Supplement: List of included full text studies, list of excluded full text studies with reason and list of ongoing, withdrawn, and completed studies
2) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update
3) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
4) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update
1) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs Supplement: List of included full text studies, list of excluded full text studies with reason and list of ongoing, withdrawn, and completed studies
2) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update
3) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
4) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update
TRP-20211004-1860_0.pdf
726.2 KB
European Centre for Disease Control: Xmas bundle (Drop 4 of 5)
1) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
2) Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
3) Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts Version 2.0
4) Supplementary document 1 (for paper 3): Informed consent form
5) Supplementary document 2 (for paper 3): Statistical analysis plan
6) Supplementary document 3 (for paper 3): Guidelines for laboratory testing
1) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
2) Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
3) Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts Version 2.0
4) Supplementary document 1 (for paper 3): Informed consent form
5) Supplementary document 2 (for paper 3): Statistical analysis plan
6) Supplementary document 3 (for paper 3): Guidelines for laboratory testing